Best of May: Top 5 Insights In Drug Formulation & Delivery

#1 - Design Controls For Drug Delivery Devices, Part 2: A Practical Perspective

In this article, Fran DeGrazio provides recommendations for implementing Design Controls in the development of combination products and other drug delivery devices.

#2 - Developing Therapy Delivery Options For Autoimmune And Allergic Diseases At Revolo Biotherapeutics

In this episode of In Combination, host Tom von Gunden combines the perspectives of three executives at Revolo Biotherapeutics in a discussion about developing and delivering peptide-based alternatives to steroids for allergic and autoimmune diseases.

#3 - Smart Drug Delivery Systems: Emerging Market Trends

According to new market research, the global smart drug delivery systems market reached $12 billion in 2024 and is expected to grow at a CAGR of 17% from 2025 to 2034. Check out this article for product trends and more.

#4 - Hospital To Home: What It Means For Patients, Providers And Medical Devices

As the line between hospital and home continues to blur, designing with the end user in mind isn’t just good practice—it’s essential for better outcomes. Explore how Battelle is applying a human-centered design approach to medical device development.

#5 - The Future Of Biologics Delivery: High-Concentration Subcutaneous Injectables

Once dominated by IV infusions administered in hospital settings, the biologics industry is now at a crossroads.Here's why the future of biologics delivery is high-concentration subcutaneous injectables.